Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Jan 16, 2022 (Letter of inquiry)

Later deadlines: Feb 16, 2022 (Full proposal)

Grant amount: Up to US $3,250,000

Fields of work: Neurological Diseases & Disorders

Applicant type: Organizations

Funding uses: Non-clinical Biomedical, Non-clinical Behavioral

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: 

  • Applications are due by 5 pm submitter's local time. 
  • Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical studies that address critical needs for clinical trial readiness in rare neurological and neuromuscular diseases. These studies should result in clinically validated biomarkers and clinical outcome assessment measures appropriate for use in upcoming clinical trials. Through the support of trial readiness studies, NINDS and NCATS expect to enhance the quality and increase the likelihood of success of clinical trials in these rare diseases.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed March 19, 2019 and last updated March 19, 2019